MEDIDELIC
Live / Registered — Registered (as of 06 Feb 2024)
What this means for you
Registered since 06 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90506292
- Registration number
- 7299931
- Mark type
- Stylized text
- Filed
- 03 Feb 2021
- Published for opposition
- 07 Dec 2021
- Registered
- 06 Feb 2024
- Attorney of record
- Dean H. Kayes
Goods and services
- Class 042 — Scientific and technological services: Biotechnology research; Research and development in the pharmaceutical, bioenergetic imprinting and biotechnology fields; Providing information on the subject of scientific research in the field of biochemistry, biological signaling and biotechnology; Development of new technology for others in the field of biotechnology; Scientific Research and Development of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) modeling, physiologically based pharmacokinetic (PBPK) and physiologically based biopharmaceutics (PBBM) modeling and simulation software for the pharmaceutical and biotechnology industries; Research and Development of software that allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research and development costs and helping clients make better projects decisions sooner that includes PBBK (Physical based pharmacokinetics), PBBM (Physiologically based biopharmaceutics), NOAEL (No observed adverse effect level); Scientific Research and Development utilizing a proprietary algorithm and artificial intelligence that utilizes a combination of lifestyle, hospitalization, emergency room use, mortality and outcomes data to assist the healthcare industry and workers in identifying groups at high risk and populations that can benefit from various therapeutic approaches; Scientific Research and Development of drugs and therapies through applying interactive maps that identify ideal target populations for various therapeutic approaches including the mapping of surfaces that apply socio, economic and environmental factors such as access to or lack of access to transportation or nutritious food, or exposure to high stress and artificial intelligence analysis considering the suitability of various drugs or therapies
Owner
- Newman, David, Phoenix, AZ, US
- Newman, David, Phoenix, AZ, US
- Newman, David, Phoenix, AZ, US
Prosecution history
- 06 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Jan 2024 — ELECTRONIC RECORD REVIEW COMPLETE
- 22 Dec 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 20 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Dec 2023 — EXAMINER'S AMENDMENT ENTERED
- 19 Dec 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 19 Dec 2023 — EXAMINERS AMENDMENT E-MAILED
- 19 Dec 2023 — SU-EXAMINER'S AMENDMENT WRITTEN
- 04 Sept 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 04 Sept 2023 — FINAL REFUSAL E-MAILED
- 04 Sept 2023 — SU - FINAL REFUSAL - WRITTEN
- 31 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED